Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;26(9):1057-1069.
doi: 10.1007/s11912-024-01566-x. Epub 2024 Jun 27.

Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment

Frodita Jakimovska  1   2 , Igor Stojkovski  3 , Elena Kjosevska  4
Affiliations

Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment

Frodita Jakimovska et al. Curr Oncol Rep. 2024 Sep.

Abstract

Purpose of review: The purpose of this review is to analyze the diagnosis and treatments of the sinonasal malignant tumors throw systematic reviewed literature. The systematic review of the literature was performed according to PRISMA guidelines.

Recent findings: Total 11,653 cases of five article were analyzed. The cohort of 3824 cases received appropriate treatment. The most frequent histotype of the group of sinonasal malignancies was squamous cell carcinoma. Squamous cell carcinoma was represented by 54%. The other histopathological subtypes were esthesioneuroblastoma with 9,9%, melanoma 9,8%, adenocarcinoma 7,5%, sarcoma 7,3%, adeno cystic carcinoma 7,1%, sinonasal undifferentiated carcinoma 3,9%, sinonasal neuroendocrine carcinoma 2,8% respectively. All 772 cases of total 3824 were treated only surgically. All 62 cases of total 3824 were treated without surgery, 20 cases with proton technique and SFUD, and 42 cases with proton technique and IMRT. The other 2990 cases of total 3824 were treated with multimodality treatment. The diagnosis and treatment of sinonasal cancers require a interdisciplinary approach and multimodality treatment.

Keywords: Histopathology; Radiotherapy; Sinonasal carcinomas; Sinonasal malignancies; Surgery; Treatment.

PubMed Disclaimer

References

    1. Thawani R, Kim MS, Arastu A, Feng Z, West MT, Taflin NF, Thein KZ, Li R, Geltzeiler M, Lee N, Fuller CD, Grandis JR, Floudas CS, Heinrich MC, Hanna E, Chandra RA. The contemporary management of cancers of the sinonasal tract in adults. CA Cancer J Clin. 2023;73(1):72–112. Epub 2022 Aug 2. PMID: 35916666; PMCID: PMC9840681. - DOI - PubMed
    1. Bracigliano A, Tatangelo F, Perri F, Di Lorenzo G, Tafuto R, Ottaiano A, Clemente O, Barretta ML, Losito NS, Santorsola M, Tafuto S. Malignant sinonasal tumors: update on histological and clinical management. Curr Oncol. 2021;28(4):2420–38. https://doi.org/10.3390/curroncol28040222 . PMID: 34287240; PMCID: PMC8293118. - DOI - PubMed - PMC
    1. Shirley Y. Su1 Diana Bell2 Ehab Y. Hanna1 Esthesioneuroblastoma, Neuroendocrine Carcinoma, and Sinonasal Undifferentiated Carcinoma: differentiation in diagnosis and. Treat Int Arch Otorhinolaryngol. 2014;18:S149–56. - DOI
    1. Lucidi D, Cantaffa C, Miglio M, Spina F, Alicandri Ciufelli M, Marchioni A, Marchioni D. Tumors of the nose and paranasal sinuses: promoting factors and molecular mechanisms—a systematic review. Int J Mol Sci. Molecular and cytogenetic studies on the pathogenesis of these heterogeneous cancers are lagging behind. New clinical trials are needed to define new therapeutic strategies. 2023;24(3):2670. https://doi.org/10.3390/ijms24032670 .
    1. Akay S, Pollard JH, Saad Eddin A, Alatoum A, Kandemirli S, Gholamrezanezhad A, Menda Y, Graham MM, Shariftabrizi A. PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms. Cancers (Basel). 2023;15(15):3759. https://doi.org/10.3390/cancers15153759 . PMID: 37568575; PMCID: PMC10417627. - DOI - PubMed

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources